Addiction & Stroke

Launched by UNIVERSITY HOSPITAL, BORDEAUX · Dec 15, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Addiction & Stroke," is looking to understand how making lifestyle changes can help prevent further strokes in patients who have recently experienced one. The study focuses on individuals who have had a stroke or a mini-stroke and aims to explore the importance of modifying risk factors, such as quitting smoking and improving diet, to reduce the chances of another stroke.

To be eligible for this trial, participants must be between 18 and 80 years old and have had a stroke within the last 15 days. They should also be able to return for a follow-up appointment at the Bordeaux Hospital, have a certain level of stroke severity, and be able to provide consent. Participants will need to use a smartphone and live in an area with internet access. If you decide to join, you can expect support in making these lifestyle changes and monitoring your progress to help improve your health after a stroke.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female
• • At least 18 years of age and younger than 80 years;
• • Recent (≤ 15 days) clinically symptomatic ischemic or hemorrhagic stroke documented through brain imaging (CT or MRI) or a Transient Ischemic Attack with an ABCD2 score ≥ 4;
• • Returning to the Bordeaux Hospital neurovascular unit for the standard care 3-months post-stroke follow-up visit;
• • National Institute Health Stroke Scale (NIHSS) \< 15;
• • modified Rankin scale ≤ 4;
• • No severe cognitive impairment as defined by the neurologist;
• • Written informed consent by the patient;
• • Coverage by the French National Health Insurance.
• • For the feasibility study assessing the acceptability of the eHealth device to optimize stroke secondary prevention, additional inclusion criteria will be the ability to use a smartphone and living in an area with internet coverage.
• Exclusion Criteria:
• • Subarachnoid hemorrhage; Dementia syndrome or other neurologic disorder;
• • Severe aphasia (NIHSS item 9 ≥ 2) and/or Severe visual impairment interfering with the completion of evaluations;
• • Severely impaired physical and/or mental health that, according to the neurologist, may affect the participant's capacity to participate in the study;
• • Pregnancy or breastfeeding;
• • Inability to read French;
• • Individuals under legal protection or unable to personally express their consent
• • Participation in another protocol modifying the patient's follow-up status